Product Images Lumisight
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Lumisight NDC 82292-040 by Lumicell, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image description - spl 1
image description - spl 2
image description - spl 3
LUMISIGHT is an injectable medication containing 39 mg per vial of pegulicianine. After reconstitution with 0.45% Sodium Chloride Injection, USP, it is intended for intravenous use. The medication comes in packages of 10 single-dose vials. The reconstitution process involves adding 4 mL of the sodium chloride solution per vial for withdrawal of 3.9 mL. The product is distributed by LUMICELL and can be found at 275 Washington Street, Suite 20, Newton, MAT24545.*
table1 - table 1
This is a table that shows the image-level performance of LUMISIGHT for detecting residual breast cancer in the lumpectomy cavity after the completion of standard care surgery. The table provides the number of positive and negative results from both LUMISIGHT and another imaging result, along with the total numbers. Additionally, it includes diagnostic performance metrics such as sensitivity and specificity, along with their confidence intervals. The study methodology involved regions of the lumpectomy cavity where LUMISIGHT-guided shaves were taken, and a statistical method was used to account for within-patient correlation when calculating sensitivity and specificity.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
